Karyopharm Therapeutics Inc
NASDAQ:KPTI

Watchlist Manager
Karyopharm Therapeutics Inc Logo
Karyopharm Therapeutics Inc
NASDAQ:KPTI
Watchlist
Price: 7.47 USD 0.4% Market Closed
Market Cap: 127.4m USD

Intrinsic Value

The intrinsic value of one KPTI stock under the Base Case scenario is hidden USD. Compared to the current market price of 7.47 USD, Karyopharm Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

KPTI Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Karyopharm Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

KPTI looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if KPTI is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about KPTI?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is KPTI valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Karyopharm Therapeutics Inc.

Explain Valuation
Compare KPTI to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about KPTI?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Karyopharm Therapeutics Inc

Current Assets 89.7m
Cash & Short-Term Investments 45.9m
Receivables 31.9m
Other Current Assets 12m
Non-Current Assets 6.5m
PP&E 4.8m
Other Non-Current Assets 1.7m
Current Liabilities 87.2m
Accounts Payable 5.4m
Accrued Liabilities 67.3m
Other Current Liabilities 14.5m
Non-Current Liabilities 278.3m
Long-Term Debt 250.2m
Other Non-Current Liabilities 28.1m
Efficiency

Free Cash Flow Analysis
Karyopharm Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Karyopharm Therapeutics Inc

Revenue
142.5m USD
Cost of Revenue
-5.8m USD
Gross Profit
136.7m USD
Operating Expenses
-240.9m USD
Operating Income
-104.1m USD
Other Expenses
-20.5m USD
Net Income
-124.6m USD
Fundamental Scores

KPTI Profitability Score
Profitability Due Diligence

Karyopharm Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
Exceptional Gross Margin
Strong 3Y Average Gross Margin
hidden
Profitability
Score

Karyopharm Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

KPTI Solvency Score
Solvency Due Diligence

Karyopharm Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
hidden
Solvency
Score

Karyopharm Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KPTI Price Targets Summary
Karyopharm Therapeutics Inc

Wall Street analysts forecast KPTI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KPTI is 14.89 USD with a low forecast of 6.06 USD and a high forecast of 22.05 USD.

Lowest
Price Target
6.06 USD
19% Downside
Average
Price Target
14.89 USD
99% Upside
Highest
Price Target
22.05 USD
195% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Karyopharm Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for KPTI is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

KPTI Insider Trading
Buy and sell transactions by insiders

KPTI News

Other Videos
What is the Intrinsic Value of one KPTI stock?

The intrinsic value of one KPTI stock under the Base Case scenario is hidden USD.

Is KPTI stock undervalued or overvalued?

Compared to the current market price of 7.47 USD, Karyopharm Therapeutics Inc is hidden .

Back to Top